Open Disputes at FDA Advisory Committees: Get Ready for Institutionalized Cacophony

Recent FDA advisory committees on Avandia and Ketek have featured conflicting points of view from FDA internal staff. Get ready for more public airings in the future. Influential Iowa Republican Senator Charles Grassely is directing FDA to bring all opinions into the open.